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We sought to elucidate the protein carbamoylation patterns associated with cyanate neuropathy relative to cyanide
poisoning. We hypothesized that under a diet deficient in sulfur amino acids (SAA), the carbamoylation pattern
associated with cyanide poisoning is similar to that of cyanate neuropathy. Male rats (6–8 weeks old) were fed a
diet with all amino acids (AAA) or 75%-deficiency in SAA and treated with 2.5 mg/kg/body weight (bw) NaCN, or
50 mg/kg/bw NaOCN, or 1 μl/g/bw saline, for up to 6 weeks. Albumin and spinal cord proteins were analyzed
using liquid chromatography mass spectrometry (LC-MS/MS). Only NaOCN induced motor deficits with significant
levels of carbamoylation. At Day 14, we found a diet-treatment interaction effect on albumin carbamoylation
(p = 0.07). At Day 28, no effect was attributed to diet (p = 0.71). Mean number of NaCN-carbamoylated sites on
albumin was 47.4% higher relative to vehicle (95% CI:16.7-86.4%). Only NaOCN carbamoylated spinal cord proteins,
prominently, under SAA-restricted diet. Proteins targets included myelin basic and proteolipid proteins, neurofilament
light and glial fibrillary acidic proteins, and 2', 3' cyclic-nucleotide 3'-phosphodiesterase. Under SAA deficiency,
chronic but not acute cyanide toxicity may share biomarkers and pathogenetic similarities with cyanate
neuropathy. Prevention of carbamoylation may protect against the neuropathic effects of cyanate.
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Dietary dependency on cyanogenic cassava and low intake
in sulfur amino acid (SAA) have been implicated in out-
breaks of a central motor neuron disease known as konzo.
Subjects affected by the disease present with an overt
spastic abnormality of their gait or a complete inability to
walk (Howlett et al. 1990, Tylleskar et al. 1992, Tylleskar
et al. 1994, Chabwine et al. 2011, Cliff et al. 2011, Boivin
et al. 2013). We recently showed that children from
konzo-affected areas may also present with a pervasive
cognitive dysfunction suggesting that the clinical burden
associated with cassava cyanogenic intoxication has been* Correspondence: tshalad@ohsu.edu
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in any medium, provided the original work is punderestimated (Boivin et al. 2013). The exact biomarkers
and mechanisms of the disease remain unclear. The dis-
ease mainly affects children and women of childbearing
age among sub-Saharan African populations that subsist
on food products derived from insufficiently processed
bitter and cyanogenic cassava.
Cassava is a carbohydrate-enriched and cyanogenic
crop with a very low content in proteins and only 1-2%
content in SAA, which are needed for humans to detoxify
cyanide (Diasolua Ngudi et al. 2002, Kassa et al. 2011,
Nunn et al. 2011). It contains linamarin, a cyanogenic
compound that is metabolically converted to cyanohydrins
and hydrogen cyanide, a well-known mitochondrial toxin.
Under normal conditions, cyanide (CN) is converted to
a less toxic compound i.e. thiocyanate (SCN) via the
SAA-dependent rhodanese pathway, to trace amounts
of cyanate (OCN), and to 2-iminothiazoline-4-carboxylicn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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detoxification pathways of cyanide are favored and
there is increased production of OCN, a well-known
motor system toxin (Tellez et al. 1979, Swenne et al.
1996, Spencer 1999, Tor-Agbidye et al. 1999a, Zottola
et al. 2009). Epidemiological studies have shown a link
between cassava cyanogenic exposure, protein malnu-
trition, and outbreaks of konzo (Banea-Mayambu et al.
1997, Cliff et al. 2011, Nzwalo and Cliff 2011).
Currently, research efforts focus on elucidating the
biomarkers and mechanisms of the disease. Limited
progress has been made partially due to the lack of
experimental models.
We previously showed that proteomics methodolo-
gies may help unveil biomarkers of cyanogenic expos-
ure (Kassa et al. 2011). In this study, we compared
the carbamoylation patterns of cyanate neuropathy
versus cyanide poisoning under a diet deficient in
SAA. We hypothesized that under a diet deficient in
sulfur amino acids (SAA), the carbamoylation pattern
associated with cyanide poisoning is similar to that of
cyanate neuropathy. Liquid chromatography tandem
mass spectrometry (LC-MS/MS) analysis was per-
formed on albumin and spinal cord proteins from
rodents treated with cyanide or cyanate while fed with
either a normal (all amino acid-containing) diet or a
diet deficient in SAA. NaOCN, or NaCN to a lesser
extent, carbamoylates serum albumin. SAA deficiency
exacerbates the NaOCN carbamoylation effects on se-
lect spinal cord proteins. Studies on humans affected
by cassava-associated neurological diseases are needed
to determine whether chronic cassava cyanogenic ex-

























Figure 1 Rotarod performance in rats treated with normal saline (NS)
rotarod fall off time in rats. The fall time from the rotating rod decreased si
control and NaCN overtime.Results
Motor deficits
Over the course of the study, the odds of remaining on
the rotarod for at least 60s was significantly (p < 0.05)
lower for the SAA-fed rats treated with NaOCN compared
to those treated with NaCN or vehicle. Treatment affected
the rotarod fall off time. The fall time was also significantly
(p = 0.040) shorter on the last testing day in animals
treated with NaOCN compared to control and NaCN
groups. No statistical difference was found between NaCN
relative to the control treated groups (p = 0.16) (Figure 1).
Albumin carbamoylation
There was a significant interaction between diet and
treatment with respect to mean number of assigned MS/
MS spectra to carbamoylated albumin peptides (spectral
counts) at 14-day time point (X^2(2df ) = 5.24, p = 0.073).
NaOCN overtly induced high levels of carbamoylation of
albumin relative to vehicle or NaCN regardless of the
diet (P < 0.001) (Table 1).
At the 28-day time point, there was no evidence of
interaction between diet and treatment with respect to
mean number of spectral counts for carbamoylated albu-
min peptides (X^2(2df) = 3.83, p = 0.15), thereby simplify-
ing comparisons across treatments and diets. The mean
number of spectral counts for albumin carbamoylated
peptides was 47.4% (95% CI: 16.7 - 86.4%) greater in
NaCN-treated animals relative to their vehicle-treated
counterparts (p = 0.001), regardless of diet. The carbamoy-
lation effect was amplified in animals treated with NaOCN
compared to vehicle, with the mean response for NaOCN
animals being 33.9 (95% CI: 28.0 - 41.1) times as much as
the mean response for vehicle (p < 0.001) or 23 (95% CI:
19.5 - 27.2) times the mean response for NaCN (p < 0.001) 21 25 29 33 37 
e (days) 
NaCN NaOCN 
, NaCN or NaOCN and fed SAA-restricted diet. Treatment affected
gnificantly (p <0.001) among rats treated with NaOCN compared to
Table 1 Day 14 mean number of spectral counts (95% CI
mean response) for carbamoylated albumin peptides
Diet
Treatment AAA estimates (95%CI) SAA estimates (95%CI)
Vehicle 22.5 (16.5 - 30.7) 15.8 (11.2 - 22.1)
NaCN 18.0 (13.0 - 25.0) 21.5 (15.7 - 29.4)
NaOCN 521.0 (411.0 - 660.0) 702.0 (554.0 - 888.0)
Comparisons Estimated ratios (95% CI) Estimated ratios (95% CI)
NaCN/Vehicle 0.80 (0.51 - 1.26) 1.37 (0.86 - 2.17)]
NaOCN/Vehicle 23.2 (15.7 - 34.2)* 44.5 (29.5 - 67.3)*
NaOCN/NaCN 28.9 (19.3 - 43.4)* 32.6 (22.0 - 48.3)*
NaOCN overtly (*) induced high levels of carbamoylation of albumin relative to
vehicle or NaCN regardless of the diet.
Table 3 Day 28/Day14 ratios (95% CI) of mean numbers
of spectral counts for carbamoylated albumin peptides
Diet
Treatment AAA ratios (95% CI) SAA ratios (95% CI)
Vehicle 1.06 (0.80 - 1.40) 0.80 (0.61 - 1.07)
NaCN 1.55 (1.20 - 2.01)* 1.18 (0.91 - 1.53)
NaOCN 1.17 (0.94 - 1.46) 0.89 (0.71 - 1.11)
Comparison of the levels of albumin carbamoylation at day 28 vs. day 14
revealed increased carbamoylation (*) in the group of animals treated with
NaCN and fed with a normal diet.
Table 4 NaOCN-induced mean numbers of carbamoylated
sites (95% CI the mean response) on spinal cord proteins
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nificant differences in carbamoylation that could be attrib-
uted to diet (p = 0.71).
When comparing the levels of albumin carbamoyla-
tion at Day 14 vs. Day 28, we found no evidence of an
interaction between diet and treatment (X2(2df ) = 2.27,
p = 0.32). With the exception of animals treated with
NaCN under the normal AAA diet, the relative change
in levels of carbamoylation was not significant. In the
NaCN/AAA group, the mean number of spectral counts
for carbamoylated albumin peptides was estimated to in-
crease 55% (95% CI: 20 - 101%; p = 0.001) over the 14-day
span. All other entries, however, showed relative changes
not significantly different (p ≥ 0.15) from unity (Table 3).
Spinal cord proteomics
On the last experimental day, we found a differential
pattern of susceptibility to carbamoylation in spinal cord
proteins. Carbamoylation was almost exclusively induced
by NaOCN so that comparisons between diets were lim-
ited to this one neurotoxicant. NaOCN-targeted proteins
included myelin basic protein (MBP), myelin proteolipid
protein (MPP), neurofilament light polypeptide (NFLP),
glial fibrillary acidic protein (GFAP), and 2', 3' cyclic-
nucleotide 3'-phosphodiesterase. MBP was 18.8% (95% CI:
2.3 - 38.1%; p = 0.024) more carbamoylated in animals
under the SAA-restricted diet relative their AAA counter-
parts. With regard to MPP, animals in the SAA-restrictedTable 2 Day 28 mean number of spectral counts (95% CI
mean response) for carbamoylated albumin peptides
Diet
Treatment AAA estimates (95% CI) SAA estimates (95% CI)
Vehicle 17.3 (14.3 - 20.9) 16.9 (14.0 - 20.5)
NaCN 25.5 (21.7 - 30.0) 25.0 (21.2 - 29.4)
NaOCN 587.0 (535.0 - 644.0) 574.0 (525.0 - 629.0)
Carbamoylation effects were significantly seen in NaCN and NaOCN-treated
animals relative to their vehicle-treated counterparts, with a pronounced effect
of NaOCN regardless of the diet.diet had 23.3% (95% CI: 5.8 - 43.7%; p = 0.007) more car-
bamoylation sites compared to their AAA counterparts.
Similarly for NFLP, the SAA-restricted diet had an impact
on carbamoylation. Under the SAA-restricted diet, the an-
imals had 39% (95% CI: 2.6 - 88.2%; p = 0.03) more carba-
moylation sites relative to their AAA counterparts. For
GFAP, the SAA-deficient group had 34.2% (95% CI: 5.9 -
69.9%; p = 0.02) more carbamoylation sites relative to the
AAA-group. With regard to 2', 3' cyclic-nucleotide 3'-
phosphodiesterase, the SAA-restricted diet produced an
average number of carbamoylation sites that was 2.85
(95% CI: 1.8 - 4.5; p < 0.001) times the corresponding aver-
age response of animals fed the normal AAA diet
(Table 4).
None of the animals in the Vehicle- or NaCN-treated
groups (either diet) had any carbamoylated sites for
MBP or GFAP. For MPP, only one animal had 1 carba-
moylated site in the Vehicle/AAA group; all other Ve-
hicle and NaCN treatments (both diets) were otherwise
uniformly silent. For the NFLP, only one animal had 1
carbamoylated site in the NaCN/SAA group; all other
Vehicle and NaCN treatments (both diets) were other-
wise uniformly silent.
Discussion
We used state-of-the art proteomic methodologies to reveal
differential carbamoylation patterns associated with cyanate
neuropathy versus cyanide poisoning under conditions ofProtein AAA Diet 75% SAA-
Deficient diet
Myelin basic protein 78.25 (70.0 - 87.4) 93 (84.0 – 102.0)
Myelin proteolipid protein 74 (66.0 – 82.9) 91.25 (82.4 – 101.0)
Neurofilament light
polypeptide
48.75 (39.0 – 60.8) 67.75 (55.0 - 83.4)
Glial fibrillary acidic protein 30 (25.1 - 35.9) 40.25 (34.5 - 47.0)
2', 3' cyclic-nucleotide 3'-
phosphodiesterase
6.5 (4.4 – 9.6) 18.5 (14.6 – 23.5)
Carbamoylation pattern in spinal cord proteins indicates an exacerbating
effect of the SAA-deficient diet, mostly for 2', 3' cyclic-nucleotide
3'-phosphodiesterase.
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moylated albumin may be a useful marker of exposure to
cyanate and carbamoylating derivatives or precursors such
as urea. Only NaOCN induced motor deficits and signifi-
cant carbamoylation of albumin and select spinal cord
proteins. On the assumption that these findings would
hold true for additional experimental time points and time
dependent correlations between levels of carbamoylation
and NaOCN-induced deficits in a large sample of rats, our
results suggest that cyanate neuropathy may be mediated
through carbamoylation. This proposal is consistent with
earlier studies that have shown a positive correlation
between memory deficits and levels of carbamoylation in
rat brain (Crist et al. 1973) or suggested that carbamoy-
lated albumin may be clinically used to predict risks for
neuropathy in uremic patients (Kraus and Kraus 2001,
Berg et al. 2013, Kalim et al. 2013). The observed pattern
of carbamoylation is consistent with the myelinotoxic
effects of cyanate as previously reported (Ohnishi et al.
1975, Tellez-Nagel et al. 1977, Tellez et al. 1979). NaOCN
targets include major myelin proteins and corresponding
binding proteins such as neurofilament light polypeptide,
glial fibrillary acidic protein, and 2', 3' cyclic-nucleotide 3'-
phosphodiesterase; with the latter showing a greater
carbamoylation effect. The impact of NaOCN on 2', 3'
cyclic-nucleotide 3'-phosphodiesterase and, hence,
functions of 2',3'-cyclic nucleotides to 2'-nucleotides in
relation to microtubules and cytoskeleton organization,
and cell survival, needs further attention. Establishing a
model of cytoskeletal disorganization in response to cy-
anogenic poisoning may be relevant for testing of drug
candidates including the neuroprotective peptide NAP
(Zemlyak et al. 2009). The aforementioned pattern of
protein susceptibility to carbamoylation should inform
such studies to elucidate the exact pathways and mecha-
nisms leading to cyanate neuropathy (Han et al. 2013).
The exacerbating effect of dietary SAA-deficiency on
the carbamoylation of the aforementioned proteins has
yet to be explained. In serum, SAA deficiency had no
impact on the carbamoylation of albumin after 28-days
of treatment with cyanate. This may possibly be ex-
plained by a “sulfur buffering effect” by abundant
serum sulfur donors including albumin (Westley et al.
1983). Lack of increase in cyanate carbamoylation on
day 28 relative to day 14 may be due to a metabolic
clearance of carbamoylated proteins. For cyanide, how-
ever, the increase in levels of carbamoylation could
simply portray a cumulative effect of cyanide detoxifi-
cation with cyanate production and subsequent carba-
moylation of albumin. This proposal would need,
however, to be confirmed with quantitative measures
of tissue contents in cyanide, cyanate, and SAA; which,
along with a small sample size, are among the limita-
tions of this study.Within our study time frame, we failed to confirm the
primary hypothesis that under SAA deficiency, acute
cyanide toxicity induces carbamoylation patterns similar
to that of cyanate neuropathy. However, in light of the
observed response on albumin, chronic exposure to
cyanide may conceivably lead to greater carbamoylation
effects. This hypothesis should be tested on subjects
chronically exposed to cyanide notably those living in
konzo-affected areas. In these undernourished subjects,
cyanide is hypothesized to undergo oxidative detoxification
with subsequent increase in the production of cyanate, a
well-known carbamoylating neurotoxin. The neurotoxic in-
sults seen in these subjects could arise from a “multiple hit”
process that combines of a direct mitochondrial hit by
cyanide, a protein hit through carbamoylation, and a thiol-
redox hit due to SAA-deficiency (Tor-Agbidye et al. 1999a,
Tor-Agbidye et al. 1999b, Kassa et al. 2011, Berg et al.
2013). Since only NaOCN-treated animals developed motor
toxicity and carbamoylation of spinal cord proteins, our
findings are in favor of a recent proposal that suggests that
blocking carbamoylation may have neuroprotective effects
in uremic subjects (Berg et al. 2013).
Conclusion
The carbamoylation and neurotoxicity effects of cyanate
may be influenced by diet with an exacerbating effect of
dietary deficiency in sulfur amino acids. Cyanate hits
proteins that are important in maintaining the shape
and organization of the cytoskeleton, and hence, sup-
porting mechanisms of neuronal survival. Proteins tar-
gets included myelin basic and proteolipid proteins,
neurofilament light and glial fibrillary acidic proteins,
and 2', 3' cyclic-nucleotide 3'-phosphodiesterase. Under
SAA deficiency, chronic but not acute cyanide toxicity
may share biomarkers and pathogenetic similarities
with cyanate neuropathy. Prevention of carbamoylation
may protect against the neuropathic effects of cyanate.
Studies on the biomarkers and mechanisms of food
(cassava) associated neurological diseases should consider
the potential role of cyanate and its carbamoylation effects
as endpoints of interest both at the experimental, clinical,
and public health standpoints.
Materials and methods
Chemicals
Sodium cyanide (NaCN CAS No. 143-33-9, 97.2% purity)
and cyanate (NaOCN CAS No. 917-61-3, 96% purity)
were bought from Sigma–Aldrich (St. Louis, MO) and
stored at room temperature. All other laboratory reagents
were of analytical or molecular biology grades.
Animals
Young adult male heterozygous rats (Crl: NIH-Fox1 rnu/
Fox 1+, 6–8 weeks old) (N = 52), weighing 140-210 g upon
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Neurology, Oregon Health & Science University (OHSU).
They were caged in an animal room maintained on a 12/
12 h light/dark cycle in the Center for Research on Occu-
pational and Environmental Toxicology (CROET). Food
and water were given ad libitum. Experimental protocols
were approved by the OHSU institutional animal care and
use committee (IACUC).
Diet and dosing regimens
Diet
Custom-synthesized isonitrogenous rodent diet with ei-
ther all amino acids (AAA-diet; code TD09460) or lack-
ing 75% of the SAA-content relative to the control diet
(SAA-deficient diet; code TD09463) were purchased
from Harlan (Madison, WI) and stored at 4°C until use.
We chose a 75%-deficient but not free SAA to allow for
animal survival and cyanide detoxification since previ-
ous experimentation showed animals fed with SAA-free
chow had dramatic weight loss and muscle weakness
(Tor-Agbidye et al. 1999a).
Dosing regimens
Animals were first acclimated for a 5-day period on a diet
consisting of 4:1 portions of normal rodent chow (PMI
Nutrition International, NJ) with either AAA-diet (N = 28)
or 75%-SAA deficient diet (N = 24). On the 6th day, they
were assigned to experimental groups (N = 7-10/group)
and treated intraperitoneally (one injection per day) for up
to 6 weeks as follows: (Banea-Mayambu et al. 1997) AAA-
diet, 2.5 mg/kg body weight (bw) NaCN; (Berg et al. 2013)
AAA-diet, 50 mg/kg bw NaOCN; (Boivin et al. 2013)
AAA-diet, equivalent amount of vehicle (1 μl/g bw saline);
(Chabwine et al. 2011) SAA-deficient diet, 2.5 mg/kg bw
NaCN; (Cliff et al. 2011) SAA-deficient diet, 50 mg/kg bw
NaOCN; (Crist et al. 1973) SAA-deficient diet, equivalent
amount of vehicle (1 μl/g bw saline). Dose selection for
cyanide was informed by previous findings of sublethal
and/or lethal cyanide poisoning prior to konzo outbreaks
(Banea-Mayambu et al. 1997). Cyanate was given at doses
similar to doses known to induce neuropathy in humans
(Ohnishi et al. 1975).
Specific protocols
Animal observations
Rodents were examined daily in an open field for phys-
ical signs including walking difficulties, tremors and
hind limb extension reflexes, which were elicited when
the animal was gently raised by the tail. Motor function
was assessed by animal performance on an accelerating
rotating rod. Animals were individually placed on rotating
rods in a software-driven rotarod apparatus (AccuScan
Instruments, Inc., Columbus, OH) set in an accelerating
mode. The rotation speed was gradually increased from 5to 25 r.p.m. The apparatus had an automatic system for
fall detection via photobeams. Rotarod performance was
analyzed to estimate how odds of remaining on the rod
for at least 60 seconds changed over time. Testing was car-
ried out only in animals maintained on SAA diet to deter-
mine whether SAA dietary restriction had an impact on
the toxicity of cyanide, our main experimental paradigm
of interest.
Tissue preparation for proteomics
Serum samples were obtained on day 14 and 28 of the
study period. Blood was collected from the salphenous
vein using vacutainer tubes with no anticoagulants from
all rats and kept overnight at 4°C. The serum was then
collected in sterile tubes and centrifuged at 15,000 rpm
for 15 min at 4°C. Serum was aliquoted in cryotubes and
stored at -80°C till later LC-MS/MS studies. At study
termination, rats were deeply anesthetized with 4% iso-
fluorane (1 l oxygen/min) and transcardially perfused
with saline through the ascending aorta to remove the
remaining blood. The spinal cords were dissected out,
flash-frozen in liquid nitrogen, and stored at -80°C. Prior
to LC-MS/MS studies, the frozen spinal cord tissue was
thawed by adding 500 μl of 100 mM ammonium bicar-
bonate, and the tissue was uniformly dispersed by 3X15
sec of sonication (Sonic Dismembranator, Model 60,
Fisher Scientific). Samples were then centrifuged at
12,000 g for 30 min at 4°C, the supernatant removed,
the pellet re-suspended and centrifugated, and the two
supernatants pooled. The pellet was then re-suspended
in 250 μl 100 mM ammonium bicarbonate by 5 sec of
sonication as before. The protein content of the spinal
cord soluble fraction, suspended pellet, and serum sam-
ples were then determined using the BCA assay (Pierce
Chemical, Rockford, IL). The equivalent of 50 μg por-
tions of the two spinal cord fractions and serum were
then dried by vacuum centrifugation in preparation for
trypsin digestion.
Protein digestion
Fifty μg portions of dried serum, soluble and insoluble
spinal cord fractions were dissolved in 50 μl of 100 mM
ammonium bicarbonate containing 1 mg/ml of Rapigest
detergent (Waters Corp., Milford, MA). Eight μl of
50 mM dithioerythritol (DTT) solution was then added
and the samples incubated for 60 min at 60º C, followed
by addition of 8 μl of 150 mM iodoacetamide solution
and incubation at room temperature for 30 min. An
additional 16 μl of 50 mM DTT was then added, samples
incubated at room temperature for an additional 15 min,
and 20 μl of 0.1 μg/μl proteomics grade trypsin added
(Sigma Chemical Co., St Louis, MO). Following an over-
night incubation at 37°C, samples were acidified by
addition of 0.5% trifluoroacetic acid (final concentration),
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for 10 min, and the supernatant frozen prior to analysis of
peptides by mass spectrometry.
Mass spectrometric analysis
Ten μg samples of peptide digests were injected onto a
trap cartridge (Michrom Bioresources, Auburn, CA) at
20 μl/min, samples were washed for 5 min with 2%
acetonitrile, 0.1% formic acid, and the trap cartridge
placed in-line with a 0.5 × 250 mm SB-C18 reverse
phase column (Agilent Technologies, Santa Clara, CA).
Peptides were then eluted using a 200 min gradient ofFigure 2 Tryptic digests from serum (A) and insoluble spinal cord pro
mixed and analyzed by LC-MS/MS using an inclusion list for the carb
to carbamoylated peptides (spectral counts) were plotted as a function of
rats to determine the linearity of the carbamoylation assay for serum album7-30% acetonitrile containing 0.1% formic acid at a flow
rate of 10 μl/min. Peptide m/z values (MS spectra) and
fragment ions (MS/MS spectra) were collected using
an LTQ linear ion trap mass spectrometer (Thermo
Scientific, San Jose, CA) with an ion max electrospray
source fitted with a 34Ga metal needle. Each survey MS
spectrum from 400–2000 m/z was followed by 3 data-
dependant MS/MS spectra on the 3 most intense ions
found in each survey MS spectrum. The instrument used
the dynamic exclusion feature of its control software to
ignore previously analyzed ions (repeat count of 1,
maximum exclusion list of 50, and 30 sec exclusionteins (B) from cyanate-treated and vehicle-only treated rats were
amoylated peptides. The resulting numbers of MS/MS scans assigned
the % serum and insoluble spinal cord protein from cyanate-treated
in and insoluble spinal cord proteins.
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ion accumulation time of 200 m/sec, and AGC targets of
30,000 and 10,000, respectively, for MS and MS/MS
spectra.
MS/MS spectra from each analysis were converted to
dta files using Bioworks 3.3 (Thermo Scientific) and each
MS/MS spectrum matched to peptide sequences in a
database using the program Sequest (Version 27, rev. 12,
Thermo Scientific). Searches were performed with a
static modification of +57 on cysteines for carboxyimi-
domethylation, and differential modifications of +16 for
oxidation of methionines, and +43 for carbamoylation of
lysines. The search also used trypsin specificity. A database
of rat sequences was created from the Uniprot database
(Swiss Bioinformatics Institute, Geneva, Switzerland)
downloaded in Feb. 2011 (15,524 entries), the sequences
of common contaminants added, and the database
amended with sequence reversed entries to estimate
peptide false discovery rates. Sequest results were then
processed using the program Scaffold (version 4.0.5,
Proteome Software, Portland, OR) to produce a list of
identified peptides and their carbamoylation sites. Pep-
tide and protein confidence levels of 95% and 99% were
used, and a minimum of 2 unique peptides matching
each protein entry was required.
Since few carbamoylated peptides were detected in the
soluble fraction of spinal cord, further analysis to test for
differences in the level of carbamoylation between differ-
ent treatment groups was only performed for serum and
spinal cord insoluble fractions. Differences in levels of car-
bamoylation in various treatment groups was determined
by tabulating the numbers of MS/MS spectra assigned to
carbamoylated peptides from albumin in serum digests,
and the proteins myelin basic protein, neurofilament light
polypeptide, 2’3’-cyclic-nucleotide 3’-phosphodiesterase,
myelin proteolipid protein, and glial fibrillary acidic pro-
tein in digests of water-insoluble proteins from spinal
cord. Inclusion lists for each of the identified carbamo-
lyated peptides was created by specifying the m/z value for
each in the instrument’s control software. This maximized
the collection of MS/MS spectra for carbamoylated pep-
tides during the quantitative analysis so that a shorter data
collection period was required. This mass spectrometric
analysis was identical to those described above. However
they used a 60 min gradient, inclusion lists specifying the
m/z values of the targeted carbamoylated peptides, and
the dynamic exclusion feature of the instrument’s control
software was disabled. Differences in the level of carba-
moylation in various sample groups was then calculated
by summing the numbers of MS/MS scans (spectral
counts) assigned to carbamoylated peptides from the tar-
get proteins in each sample. The MS/MS scans collected
during the analysis were again searched using Sequest
using the same database and differential searches formodified peptides as before. However, due to the size of
the result files, the Sequest results were filtered using
PAW software (Wilmarth et al. 2009), which controlled
peptide false discovery using numbers of matches to the
sequence reversed entries. Peptides identified as being
carbamoylated were separately filtered from unmodified
peptides to maintain their false discovery rate below 5%.
The linearity of the carbamoylation detection was tested
by mixing protein digests from cyanate and vehicle
treated animals from the sulfur deficient diet group
(Figure 2). The numbers of identified carbamoylated
peptides as a function of percent cyanate treated serum
or spinal cord protein was determined following
Sequest searches and filtering of MS/MS data using
Scaffold as described above.
Statistical analysis
The rotorod performance was analyzed using general-
ized estimating equations (GEE) to estimate the odds of
remaining on the accelerating rotating rod for at least
60s changed over time (per each additional day of treat-
ment). At study termination, a secondary analysis of the
performance on the rotorod was conducted. An overall
(log-rank) test on the time needed to fall off the rotorod
among the three groups was carried out. Numbers of
carbamoylated sites per protein were assumed to follow
a Poisson distribution with the mean number of sites
dependent upon diet, treatment, or the interaction be-
tween the two. GEE was again used to account for the du-
plicate samples collected within each animal. Statistical
significance was set at 0.05 (0.10 for interaction effects); all
p-values are two-sided and confidence intervals set to 95%
coverage.
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